Ondine Biomedical, Inc.LSE: OBI

Capital Access Window - Ondine Biomedical Inc

· Issued by Ondine Biomedical, Inc. via RNS

On 6ix: 6ix.com/news/capital-access-window-ondine-biomedical-inc-1

Watch Ondine Biomedical's latest callOndine Biomedical (LSE:OBI) — Investor Presentation of Phase 3 Topline Results · Replay · Sep 10Read the transcript of Ondine Biomedical (LSE:OBI) — Investor Presentation of Phase 3 Topline Results

NOTICE

20/10/2026 7:30am

RESTORATION OF TRADING ON AIM

ONDINE BIOMEDICAL INC

Trading on AIM for the under-mentioned securities was temporarily suspended, pursuant to a Capital Access Window. The Capital Access Window has closed and trading restored from 20/10/2026 7:30am, an announcement having been made.

COMMON SHARES OF NO PAR VALUE, FULLY PAID (CDI)

(BNZGQK5) (CA68234M2058)

If you have any queries relating to the above, please contact the Company's nominated adviser on +44 (0)20 7409 3494.

Ondine Biomedical, Inc. on 6ix

Story so far

Earlier from Ondine Biomedical

Later from Ondine Biomedical

All Ondine Biomedical news releases